Scarica l'app Stockscreener
0.1268
6.11%
0.0073
Dopo l'orario di chiusura:
.13
0.0032
+2.52%
Precedente Chiudi:
$0.1195
Aprire:
$0.1164
Volume 24 ore:
7.14M
Relative Volume:
1.70
Capitalizzazione di mercato:
$421.73K
Reddito:
$4.02M
Utile/perdita netta:
$-4.73M
Rapporto P/E:
-0.0301
EPS:
-4.21
Flusso di cassa netto:
$-5.85M
1 W Prestazione:
-35.63%
1M Prestazione:
-89.34%
6M Prestazione:
-98.21%
1 anno Prestazione:
-99.18%
Intervallo 1D:
$0.1152
$0.1396
Intervallo di 1 settimana:
$0.101
$0.21
Portata 52W:
$0.101
$18.00
Petros Pharmaceuticals Inc Stock (PTPI) Company Profile
Nome
Petros Pharmaceuticals Inc
Settore
Telefono
973-242-0005
Indirizzo
1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK
Confronta PTPI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PTPI
Petros Pharmaceuticals Inc
|
0.1268 | 421.73K | 4.02M | -4.73M | -5.85M | -4.21 |
|
ZTS
Zoetis Inc
|
160.41 | 66.72B | 9.29B | 2.52B | 2.28B | 5.57 |
|
HLN
Haleon Plc Adr
|
10.45 | 48.08B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.72 | 47.74B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.48 | 18.49B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
308.07 | 13.31B | 2.76B | 1.11B | 898.10M | 22.77 |
Petros Pharmaceuticals Inc Borsa (PTPI) Ultime notizie
Petros Pharmaceuticals enhances AI for Rx-to-OTC switch platform By Investing.com - Investing.com India
Petros Pharmaceuticals enhances AI for Rx-to-OTC switch platform - Investing.com
Petros Pharmaceuticals (PTPI) Boosts AI Platform with Advanced F - GuruFocus
Petros Pharmaceuticals Strengthens Partnership with Market Leading Big Data Provider Implementing Key Enhancements to its AI Platform - ACCESS Newswire
Petros Pharma Upgrades AI Platform Following Trump Order to Expand OTC Drug Access - Stock Titan
Petros Pharmaceuticals Announces Reverse Stock Split By Investing.com - Investing.com Australia
Petros Pharmaceuticals Announces Reverse Stock Split - Investing.com
Petros Pharma Stock Plunges To Record Low On 1-For-25 Reverse Split, But Retail Optimism Lingers - Asianet Newsable
Petros Pharmaceuticals (PTPI) Aims to Transform with Innovative Healthcare Platform | PTPI Stock News - GuruFocus
Petros Pharmaceuticals pivots to smart healthcare tech By Investing.com - Investing.com India
Petros Pharmaceuticals pivots to smart healthcare tech - Investing.com
Press Release Distribution & PR Platform - ACCESS Newswire
Trump Healthcare Initiative Drives Petros Pharma's $38B AI Platform Innovation for OTC Drug Approvals - Stock Titan
Petros Pharmaceuticals (PTPI) Aligns with Regulatory Climate Und - GuruFocus
Petros Pharmaceuticals Partners with Blockbuster Cholesterol Drug(1) Crestor’s (rosuvastatin) OTC Switch Technology Provider - ACCESS Newswire
You might want to take a look at Petros Pharmaceuticals Inc (PTPI) now - Sete News
Trump Order To Improve Making More Drugs Available OTC Puts Wind Behind Petros’ ACNU Sails - insights.citeline.com
Petros Pharmaceuticals gears up for Rx-to-OTC switch platform - Investing.com
Petros Pharmaceuticals to effect 1-for-25 reverse stock split - TipRanks
PTPI Announces Reverse Stock Split at 1-for-25 Ratio | PTPI Stoc - GuruFocus
US Stocks Mixed; Coca-Cola Posts Upbeat Earnings - Benzinga
Petros Pharmaceuticals gears up for Rx-to-OTC switch platform By Investing.com - Investing.com UK
Trump Executive Order Validates Petros' AI Technology Platform for Revolutionary Drug Access Reform - Stock Titan
Petros Pharmaceuticals (PTPI) Stock Soars 45% Over the Week - GuruFocus
Petros Pharmaceuticals (PTPI) Enhances Rx-to-OTC Platform with A - GuruFocus
PTPI’s Stock Market Adventure: -79.26% YTD Growth Amidst Volatility - investchronicle.com
PTPI Stock Plummets, But Premarket Hints at a Possible Rebound - Own Snap
A stock that deserves closer examination: Petros Pharmaceuticals Inc (PTPI) - uspostnews.com
Petros Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference - ACCESS Newswire
Petros Pharmaceuticals Inc (PTPI) can make a big difference with a little luck - Sete News
Petros Pharmaceuticals stock hits 52-week low at $0.04 By Investing.com - Investing.com South Africa
Ratio Analysis: Unpacking Petros Pharmaceuticals Inc (PTPI)’s Price-to-Cash and Price-to-Free Cash Flow - DWinneX
Petros Pharmaceuticals stock hits 52-week low at $0.04 - Investing.com
Investing in Petros Pharmaceuticals Inc (PTPI) might be an excellent idea, but the stock is currently overvalued/undervalued – US Post News - uspostnews.com
Are Petros Pharmaceuticals Inc (PTPI) shares a good deal now? - uspostnews.com
Petros Pharmaceuticals faces delisting, stockholders approve equity changes - Investing.com Australia
Petros Pharmaceuticals faces delisting, stockholders approve equity changes By Investing.com - Investing.com Canada
Petros Pharmaceuticals Approves Key Amendments to Incorporation - TipRanks
Petros Pharmaceuticals appoints new auditor for 2025 By Investing.com - Investing.com South Africa
Petros Pharmaceuticals appoints new auditor for 2025 - Investing.com
PTPI stock plunges to 52-week low of $0.05 amid market challenges - Investing.com Australia
PTPI stock plunges to 52-week low of $0.05 amid market challenges By Investing.com - Investing.com South Africa
Petros Pharmaceuticals modifies terms with investors - MSN
A closer look at Petros Pharmaceuticals Inc (PTPI)’s stock price trends - uspostnews.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Petros Pharmaceuticals Inc Azioni (PTPI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.38%
1.22%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):